Background Coronary artery disease (CAD) is one of the most common diseases in the world. Acute coronary syndromes (ACS) represent the acute life-threatening phase of CAD. Epidemiology and management of ACS patients differ a lot between countries and there is a wide gap between guidelines and clinical practice.
Introduction
oronary artery disease (CAD) begins indolently as a fatty streak in the lining of the artery that soon progresses to narrow the coronary arteries and impair myocardial perfusion. It may present as chronic stable angina or acute coronary syndromes (ACS) in which, the atherosclerotic plaque ruptures and causes sudden thrombotic occlusion and acute ST-elevation myocardial infarction (STEMI), non-ST-elevation MI (NSTEMI) or unstable angina (UA). In STEMI, the occlusion is total, myocardial necrosis ensue with elevation of cardiac biomarkers and ST segment in the surface electrocardiography C (ECG). In the other two syndromes, the occlusion is partial or involves a minor vessel, transient or permanent ST depression and or T inversion may occur with or without elevation of cardiac biomarkers in NSTEMI or UA respectively. Because NSTEMI and UA are indistinguishable at initial evaluation, and the entity of UA is receding as the sensitivity of biomarkers of myocardial injury increases, they are often described together as NSTE-ACS (1) . Worldwide, the number of CAD deaths increased by 31% between 1990 and 2010. In 2010, CAD accounted for 13.3% of all deaths worldwide (2) . Hospitals morbidity data provided by Iraqi Ministry of Health in 2004 demonstrates a 65% increase of the hospital admission due to CAD and stroke and more than a fivefold increase in outpatient visits with the same diagnoses between 1989 and 1999 (3) . Iraq is in the top 25 countries in Middle East with age-adjusted CAD mortality rates of about 214 per 100,000 (4) . It has been projected that between 1990 and 2020, CAD mortality in the Middle East countries will increase by 146% for women and 174% for men (5) . Much of what we understand about risk and likelihood of cardiovascular disease, its incidence and prevalence are derived from 'western' data. However, there is now an increasing awareness of ethnic variations and risk, socio-cultural and socio-economic influences as well as geographical variations. In our country, because we are fighting the consequences of CAD rather than attacking its cause we may never success. We need to adopt a pro-active strategy based upon information and evidence. We initiated a limited ACS registry hoping that it would be a nidus for a national registry. The aim of the study was to assess contemporary data on clinical presentation, risk factors, management and outcomes of patients with ACS in the Medical City Complex, and to evaluate adherence to the guidelines' recommended treatment.
Methods
The reported study was a descriptive study. (6) . Patients were followed for complications and death during hospital stay.
Statistical Analysis
Continuous variables were presented as mean±standard deviation. Categorical variables were described as frequency and percentages. Continuous variables were assessed by t-test and Categorical variables by Chi-square test. The level of statistical significance was set at P value ≤ 0.05.
Results

Initial diagnosis
The study included 348 patients, 219 (63%) admitted to the CCU of BTH and 129 (37%) admitted to the CCU of ICHD. Of the 348 patients, 126 had STEMI (36.2%), 40 had NSTEMI (11.4%) and 182 had UA (52.3%). Baseline demographic and clinical characteristics are presented in Table (1) and (2) according to diagnosis and age groups respectively. Mean age of patients was 60.3±11.2 year. The youngest patient in the study was 29 yrs old and the oldest was 90 yrs old. Men constituted 61% of patients. Hypertension (47.9%) was the most significant risk factor followed by diabetes mellitus (41.6%) and smoking (31.8%). Patients with NSTE-ACS were older than STEMI patients, although statistically not significant. UA and NSTEMI patients were of similar age.
Patients with STEMI had lower prevalence of the traditional cardiovascular risk factors: diabetes and hypertension compared with NSTE-ACS patients. The patients were divided into three categories by age: < 45 years, 45-54 years and ≥ 55 years. Men predominate all age group especially the young. Risk factors differed significantly among the three age groups (table 2). In patients < 45 years old, 57% were smokers and this percentage decreased with increasing age (p = 0.001). Younger patients were more likely to have a family history of CAD (p = 0.001) and were less likely to have diabetes (P value NS) or hypertension (P = 0.022). (Table 5) . 
Discussion
Results are compared with that of GRACE study (the largest global registry that involved 6073 cases from 234 hospitals in 13 countries from Europe, North and South America, Australia, and New Zealand (7) , as well as various registries (table 6) . In this study, the median time from onset of symptoms to CCU arrival (11.9 hr) was the much later than in UAE registry (127 minutes), GRACE (140 minutes) (7) , Cairo (165 minutes) (9) and even Russia (4.33 hrs for STEMI and 7.42 hrs for NSTE-ACS) (14) or India (6 hrs) (15) . This indicates lack of awareness of alarming symptoms of ischemia and shows the need for more public health education. The mean age of our patients is significantly lower than that in European studies and higher than the Gulf and Egypt studies and so cannot be explained on economic base only; genetic and cultural factors need to be studied.
Hypertension is the most prevalent risk factor in this study. According to a population-based survey conducted in 1979 by Alwan, hypertension comprises 12% of the Iraqi population (3) . This increased to 40.4% on 2006 according to a large national survey by the Ministry of Health; the prevalence of selfreported hypertension was 19% indicating low awareness and 8.7% of patients were taking herbal or traditional remedy (16) . On 2012, a small report from selected primary health care centers in Nasiriya city reported a similar prevalence (46.1%) (17) . In a local study of 110 patients with hypertension and myocardial infarction the salt-free diet and drug noncompliance rate was seen in 69% and 71% of patients respectively (18) . All these studies indicate increasing prevalence of hypertension over time among Iraqi population but with poor patient awareness and compliance and thus less control and more complications. However, hypertension was less prevalent compared to other international studies. Whether this is related to sample volume and methodology or ethnicity, which is known to plays a major role in the prevalence of hypertension, its response to treatment and related mortality; needs to be clarified by further study (19) (20) (21) (22) . Diabetes has the highest incidence in our patients compared to other studies. According to Ministry of Health survey on 2006 diabetes affects 10.4 % of Iraqi population with 15.6% of them were taking herbal or traditional remedy for treatment (16) . A local study in Basrah involved 5,445 persons on 2014 showed that 19.7% had diabetes with 70.3% had a body mass index ≥ 25 kg/m² (23) . In another local study in Basrah included 1079 patients the mean glycated hemoglobin (HbA1c) was 9.46% ± 2.0% and only 5.5% achieved the target of HbA1c of < 7% (24) . These studies confirm that we are still lagging in diabetic control from guidelines.
Smoking is less prevalent in our study compared with international studies (7) (8) (9) (10) (11) (12) (13) . As supported by some of the aforementioned local studies, smoking ranges between 16.9 to 25%, is a finding that depends on the history given by the patient. The final diagnoses (STEMI 36.2%, and NSTE-ACS 63.7% in the form of NSTEMI 11.4% and UA 52.3% are comparable to that in the largest global registry GRACE (7) (STEMI 34% and NSTE-ACS 59% in the form of NSTEMI 30% and UA 29%), but the proportion of UA is higher than NSTEMI within our NSTE-ACS category. The use of insensitive rapid visual immunoassay for detection of cardiac biomarkers, and rare use of serial testing for biomarkers may be responsible for this overlap between NSTEMI and UA. In addition, it is possible that some of the patients were overdiagnosed because the criteria for UA are rather liberal and do not require ECG changes. Typical ischemic ECG abnormalities were absent in about 29% of UA and 10% of NSTEMI patients. In GRACE study, CAG was performed in 62% of STEMI (followed by PCI in 45% and by CABG in 4%), 57% of NSTEMI (followed by PCI in 32% and by CABG in 7%), and in 49% of UA patients (followed by PCI in 23% and by CABG in 6%) (7) . In Euro Heart Study-ACS I on 2001 and ACS II on 2004 there is significant shift from fibrinolytic therapy to primary PCI (PPCI). The use of PPCI rose from 37 to 59% (8) . In the Czech Republic, only 21% of the patients with STEMI presented to a regional hospital; the majority were referred directly to a cardiocenter by emergency medical personnel (11 ). In comparison, we have underutilization of PCI in ACSs in general and especially in STEMI due to limited availability of 24 hrs PCI facilities with expert staff and poor referral from general hospitals. In some high-income countries like in Gulf registry (Gulf RACE) (25) primary PCI was performed in 7% of cases and in a large US registry primary PCI was performed in 22% of STEMI patients (26) , suggesting the effect of administrative other than financial factors. Mortality in current study is higher than in most other studies except for Russia (14) and India (15) , which showed a similar high mortality rates (9.7 % and 6.5% respectively), similar long time to presentation and underutilization of invasive management (PCI in 18.7% of STEMI and 11.4% of NSTE-ACS in Russia registry and 8% primary PCI in India registry). While the very low mortality in Taiwan (1.3%) (27) and UAE (3.3%) (10) registries are related to exclusion of patients with > 12 hrs to presentation in the former and the high percentage of young foreign patients in the later.
Limitations
The participating two hospitals are teaching hospitals, one with primary PCI facility and one without. Thus, the present findings may not be generalized to patients of other hospital types. Lipid profile and body mass index were not checked. Only conventional coronary disease risk factors were identified. The study reports only in-hospital outcome, which may be inadequate to capture the true burden of CAD and the impact of our practice on the outcome on long term basis. This study concluded that there is a long time delay from onset of symptoms to hospital admission among our patients indicating lack of awareness of ischemic symptoms and it seems to be the most detrimental factor. There is high incidence of risk factors that can be modified by primary and secondary measures. There is underutilization of invasive management. We have a high mortality rates in patients with ACS secondary to the aforementioned factors.
